A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/17 (2006.01) A61K 8/64 (2006.01) A61K 8/98 (2006.01) A61Q 17/00 (2006.01) A61Q 19/00 (2006.01) C07K 14/47 (2006.01) C12N 15/85 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2291740
Methods for treatment of inflammatory and fibrotic conditions in vivo using UG is disclosed. Methods for treating or preventing inflammatory or fibrotic conditions characterized by a deficiency of endogenous functional UG are also disclosed. Compositions containing UG, optionally containing lung surfactant, and assay procedures for detection of UG-fibronectin complexes, are also provided.
L'invention concerne des méthodes de traitement des inflammations et des fibroses in vivo au moyen de l'utéroglobine (UG). L'invention concerne également des méthodes de traitement ou de prévention des inflammations ou des fibroses caractérisées par une déficience de l'UG fonctionnelle endogène. L'invention concerne enfin des compositions renfermant de l'UG et éventuellement un surfactant pulmonaire, ainsi que des procédures d'analyse permettant de détecter des complexes UG-fibronectine.
Mukherjee Anil B.
Pilon Aprile L.
Zhang Zhongjian
Claragen Inc.
Clarassance Inc.
National Institutes Of Health
Smart & Biggar
LandOfFree
Use of recombinant human uteroglobin in treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of recombinant human uteroglobin in treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of recombinant human uteroglobin in treatment of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2079557